Lodoxamide Tromethamine Patent Expiration

Lodoxamide Tromethamine is Used for treating ocular allergic responses in human eyes. It was first introduced by Novartis Pharmaceuticals Corp in its drug Alomide on Sep 23, 1993.


Lodoxamide Tromethamine Patents

Given below is the list of patents protecting Lodoxamide Tromethamine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Alomide US5457126 Use of lodoxamide to treat ophthalmic allergic conditions Oct 10, 2012

(Expired)

Novartis